Awards
| Award From | Category | Type | Award | Year | Center(s) | Applications | Description |
|---|---|---|---|---|---|---|---|
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | First FDA Approval: Combination Therapy for Rare Childhood Cancer, Neuroblastoma | 2015 | NCI | Therapeutics | On March 10, 2015, the Food and Drug Administration (FDA) approved Unituxin™ (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma, a rare cancer that most often occurs in young children. This approval was the result of a collaborative effort between the… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Development of First Immunotherapy to Treat Chordoma | 2016 | NCI, OD | Vaccines | Cancer vaccines harness the immune system to identify and destroy cancer cells, and are a promising new approach to fighting cancer. In contrast to preventative vaccines, cancer vaccines identify antigens from cancer cells and immunize cancer patients against those antigens to stimulate the body’s… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Discovery to Commercialization: New Immunotherapy for Rare Childhood Cancer, Neuroblastoma | 2016 | NCI | Therapeutics | On March 10, 2015, the U.S. Food and Drug Administration (FDA) approved Unituxin™ (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma, a rare cancer that most often occurs in young children. This approval was the result of a collaborative effort among the… |
United States Patent and Trademark Office (USPTO) |
Award | Patents for Humanity | Meningitis Vaccine Designed for Use in Sub-Saharan Africa | 2016 | FDA | Vaccines | Meningitis A is a devastating disease afflicting 26 countries in Africa’s meningitis belt across sub-Saharan Africa. Thousands of people would die or be disabled each year, such as the 1996-97 epidemic when 25,000 were killed and a quarter million afflicted. The disease primarily… |